Detalhe da pesquisa
1.
Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression.
J Natl Cancer Inst
; 115(11): 1404-1419, 2023 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37195421